Literature DB >> 2167675

Photoaffinity labeling of protein phosphatase 2A, the receptor for a tumor promoter okadaic acid, by [27-3H]methyl 7-O-(4-azidobenzoyl)okadaate.

S Nishiwaki1, H Fujiki, M Suganuma, M Ojika, K Yamada, T Sugimura.   

Abstract

The interaction of okadaic acid and a protein phosphatase, which is the receptor for a tumor promoter, okadaic acid, was studied. [27-3H]Methyl 7-O-(4-azidobenzoyl)okadaate was synthesized and protein phosphatase 2A, which consists of two regulatory subunits of 65 kDa and 42 kDa and a catalytic subunit of 37 kDa, was purified from bovine brain. After UV irradiation of the reaction mixture, [3H]methyl 7-O-(4-azidobenzoyl)okadaate covalently bound to the catalytic subunit, but not to the two regulatory subunits. These results strongly suggest that okadaic acid, a potent inhibitor of protein phosphatases, binds specifically to the catalytic subunit rather than to the other regulatory subunits.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167675     DOI: 10.1016/0006-291x(90)90544-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Modulation of Kv3 potassium channels expressed in CHO cells by a nitric oxide-activated phosphatase.

Authors:  H Moreno; E Vega-Saenz de Miera; M S Nadal; Y Amarillo; B Rudy
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

Review 2.  The regulation and function of protein phosphatases in the brain.

Authors:  A T Sim
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes: effect on mRNA levels for interleukin-2, IL-2R alpha, krox-24, p53, hsc70 and cyclophilin.

Authors:  F M Richards; J Milner; S Metcalfe
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 4.  The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-20       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.